Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo

Toxicology Letters

Volumn 202, Issue 3, 2011, Pages 253-260

  Zhao, Yingming ^a   Tao, Zhiwen ^a   Xu, Zhihui ^a   Tao, Zhengxian ^a   Chen, Bo ^a   Wang, Liansheng ^a   Li, Chunjian ^a   Chen, Leilei ^a   Jia, Qingzhe ^a   Jia, Enzhi ^a   Zhu, Tiebing ^a   Yang, Zhijian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Contrast medium; Endothelial cell; Toxicity

Indexed keywords

CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; IODINATED CONTRAST MEDIUM; IODIXANOL; IOPROMIDE; SODIUM; VON WILLEBRAND FACTOR;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INJURY; ARTICLE; CELL STRUCTURE; CELL ULTRASTRUCTURE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLOMERULUS BASEMENT MEMBRANE; IN VITRO STUDY; KIDNEY INJURY; KIDNEY TUBULE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGE FACTORS; ANIMALS; AORTA, ABDOMINAL; APOPTOSIS; CONTRAST MEDIA; CREATININE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; IOHEXOL; KIDNEY CORTEX; KIDNEY GLOMERULUS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; TOXICITY TESTS; TRIIODOBENZOIC ACIDS;

RATTUS;

EID: 79954590710     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.02.011     Document Type: Article

References (39)

1. Aliev G., Obrenovich M.E., Seyidova D., Rzayev N.M., Aliyev A.S., Raina A.K., Lamanna J.C., Smith M.A., Perry G. X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment. J. Submicrosc. Cytol. Pathol. 2003, 35:253-266.
2. Billings F.T.T., Chen S.W., Kim M., Park S.W., Song J.H., Wang S., Herman J., D'Agati V., Lee H.T. Alpha2-adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am. J. Physiol. Renal Physiol. 2008, 295:F741-F748.
3. Blann A., Seigneur M. Soluble markers of endothelial cell function. Clin. Hemorheol. Microcirc. 1997, 17:3-11.
4. Briguori C. Selection of contrast media: current status of understanding. G. Ital. Cardiol. (Rome) 2009, 10:79-87.
5. Chu S., Bohlen H.G. High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism. Am. J. Physiol. Renal Physiol. 2004, 287:F384-F392.
6. Duan S.B., Wang Y.H., Liu F.Y., Xu X.Q., Wang P., Zou Q., Peng Y.M. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. Acta Radiol. 2009, 50:754-759.
7. Goodman A.I., Olszanecki R., Yang L.M., Quan S., Li M., Omura S., Stec D.E., Abraham N.G. Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int. 2007, 72:945-953.
8. Heeringa P., van Goor H., Itoh-Lindstrom Y., Maeda N., Falk R.J., Assmann K.J., Kallenberg C.G., Jennette J.C. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am. J. Pathol. 2000, 156:879-888.
9. Heinrich M.C., Haberle L., Muller V., Bautz W., Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009, 250:68-86.
10. Heyman S.N., Clark B.A., Kaiser N., Spokes K., Rosen S., Brezis M., Epstein F.H. Radiocontrast agents induce endothelin release in vivo and in vitro. J. Am. Soc. Nephrol. 1992, 3:58-65.
11. Hsu S.P., Tsai T.J., Chien C.T. Ioxitalamate induces renal tubular apoptosis via activation of renal efferent nerve-mediated adrenergic signaling, renin activity, and reactive oxygen species production in rats. Toxicol. Sci. 2010, 114:149-158.
12. Jost G., Pietsch H., Sommer J., Sandner P., Lengsfeld P., Seidensticker P., Lehr S., Hutter J., Sieber M.A. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Invest. Radiol. 2009, 44:114-123.
13. Katholi R.E. Contrast-induced nephropathy-choice of contrast agents to reduce renal risk. Am. Heart Hosp. J. 2009, 7:45-49.
14. McCullough P.A. Contrast-induced acute kidney injury. J. Am. Coll. Cardiol. 2008, 51:1419-1428.
15. McCullough P.A., Bertrand M.E., Brinker J.A., Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J. Am. Coll. Cardiol. 2006, 48:692-699.
16. Mii A., Shimizu A., Masuda Y., Ishizaki M., Kawachi H., Iino Y., Katayama Y., Fukuda Y. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression. Lab Invest. 2009, 89:164-177.
17. Murakami R., Machida M., Tajima H., Hayashi H., Uchiyama N., Kumazaki T. Plasma endothelin, nitric oxide and atrial natriuretic peptide levels in humans after abdominal angiography. Acta Radiol. 2002, 43:340-343.
18. Murphy M.E., Tublin M.E., Li S. Influence of contrast media on the response of rat renal arteries to endothelin and nitric oxide: influence of contrast media. Invest. Radiol. 1998, 33:356-365.
19. Nishiyama A., Nakagawa T., Kobori H., Nagai Y., Okada N., Konishi Y., Morikawa T., Okumura M., Meda I., Kiyomoto H., Hosomi N., Mori T., Ito S., Imanishi M. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J. Hypertens. 2008, 26:1849-1859.
20. Peer A., Averbukh Z., Berman S., Modai D., Averbukh M., Weissgarten J. Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, endothelial, and hepatic cells. Invest. Radiol. 2003, 38:177-182.
21. Persson P.B., Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int. Suppl. 2006, 69:S8-S10.
22. Ramponi S., Grotti A., Morisetti A., Vultaggio S., Lorusso V. Effects of iodinated contrast media on endothelium: an in vitro study. Toxicol. In Vitro 2007, 21:191-196.
23. Romano G., Briguori C., Quintavalle C., Zanca C., Rivera N.V., Colombo A., Condorelli G. Contrast agents and renal cell apoptosis. Eur. Heart J. 2008, 29:2569-2576.
24. Rosati G. Clinical pharmacology of iomeprol. Eur. J. Radiol. 1994, 18(Suppl. 1):51-60.
25. Schiffrin E.L. Role of endothelin-1 in hypertension and vascular disease. Am. J. Hypertens. 2001, 14:83S-89S.
26. Soejima K., Uozumi J., Kanou T., Fujiyama C., Masaki Z. Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slices. Toxicol. Lett. 2003, 143:17-25.
27. Solomon R.J., Natarajan M.K., Doucet S., Sharma S.K., Staniloae C.S., Katholi R.E., Gelormini J.L., Labinaz M., Moreyra A.E. Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007, 115:3189-3196.
28. Sumimura T., Sendo T., Itoh Y., Oka M., Oike M., Ito Y., Oishi R. Calcium-dependent injury of human microvascular endothelial cells induced by a variety of iodinated radiographic contrast media. Invest. Radiol. 2003, 38:366-374.
29. Toba H., Sawai N., Morishita M., Murata S., Yoshida M., Nakashima K., Morita Y., Kobara M., Nakata T. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. Eur. J. Pharmacol. 2009, 612:106-114.
30. Toprak O., Cirit M., Tanrisev M., Yazici C., Canoz O., Sipahioglu M., Uzum A., Ersoy R., Sozmen E.Y. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol. Dial. Transplant. 2008, 23:853-859.
31. Torras J., Herrero-Fresneda I., Gulias O., Flaquer M., Vidal A., Cruzado J.M., Lloberas N., Franquesa M., Grinyo J.M. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?. Nephrol. Dial. Transplant. 2009, 24:3632-3640.
32. Tumlin J., Stacul F., Adam A., Becker C.R., Davidson C., Lameire N., McCullough P.A. Pathophysiology of contrast-induced nephropathy. Am. J. Cardiol. 2006, 98:14K-20K.
33. Wang A., Holcslaw T., Bashore T.M., Freed M.I., Miller D., Rudnick M.R., Szerlip H., Thames M.D., Davidson C.J., Shusterman N., Schwab S.J. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int. 2000, 57:1675-1680.
34. Wu C.T., Sheu M.L., Tsai K.S., Weng T.I., Chiang C.K., Liu S.H. The role of endoplasmic reticulum stress-related unfolded protein response in the radiocontrast medium-induced renal tubular cell injury. Toxicol. Sci. 2010, 114:295-301.
35. Xing C.G., Zhu B.S., Fan X.Q., Liu H.H., Hou X., Zhao K., Qin Z.H. Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice. World J. Gastroenterol. 2009, 15:5044-5052.
36. Yano T., Itoh Y., Kubota T., Sendo T., Koyama T., Fujita T., Saeki K., Yuo A., Oishi R. A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein. Am. J. Pathol. 2005, 166:1333-1342.
37. Zhang H., Holt C.M., Malik N., Shepherd L., Morcos S.K. Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br. J. Radiol. 2000, 73:1034-1041.
38. Zhang J., Duarte C.G., Ellis S. Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats. Toxicol. Pathol. 1999, 27:427-435.
39. Zhao J., Huang Y., Song Y., Zhao X., Jin J., Wang J., Huang L. Low osmolar contrast medium induces cellular injury and disruption of calcium homeostasis in rat glomerular endothelial cells in vitro. Toxicol. Lett. 2009, 185:124-131.